Future experiments are needed, for example, to determine whether the Has2 genetic deletion directly affects inflammatory cells and whether the supply of HAS2 enzyme, HMW-HA, and Hsp into the airway abrogates the lung eosinophilia. This evidence concerns the gene HSP90B2P and medical procedure.